Walter and Eliza Hall Institute researchers have uncovered a key factor protecting against age-related DNA damage, providing important clues about how our body guards against cancer.…
A NEW class of anti-cancer agents that target cancer cells’ ‘Achilles’ heel’ could help to supercharge breast cancer treatment, improving outcomes for some of the most aggressive types of breast cancer.…
Walter and Eliza Hall Institute scientist Professor Peter Colman has been appointed a Companion of the Order of Australia, Australia’s highest civilian honour, as part of the Queen’s Birthday Honours List for 2017.…
SCIENTISTS at the Walter and Eliza Hall Institute in Melbourne have discovered the cells that are thought to give rise to lung squamous cell carcinoma, the second most common subtype of lung cancer and a disease which primarily affects smokers and ex-smokers.…
VICTORIAN Premier Daniel Andrews has today announced plans to establish a translational research centre in Nanjing, following the signing of a memorandum of understanding between the Walter and Eliza Hall Institute, University of Melbourne, Cancer Trials Australia and China’s prestigious Nanjing University…
Walter and Eliza Hall Institute researchers have revealed for the first time the three-dimensional molecular ‘map’ of a protein that has been pinpointed as a driver of many types of cancers.…
Melbourne researchers have discovered that a new class of anti-cancer agents may be effective in treating multiple myeloma, an incurable bone marrow cancer.…
Walter and Eliza Hall Institute researchers have redefined how killer immune cells are mobilised in the body’s response to infections or cancer cells.…
MELBOURNE researchers have shown they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.…
NEW research shows a network of immune cells helps the appendix to play a pivotal role in maintaining the health of the digestive system, supporting the theory that the appendix isn’t a vestigial – or redundant – organ.…